Home » Topics » Conferences

Conferences
RSS

Acylides as new third-generation macrolide antibiotics

Oct. 6, 1999

P&U reports advance in the field of oxazolidinone antibacterials at ICAAC

Oct. 6, 1999

New study indicates another potential indication for pentoxifylline

Oct. 6, 1999

Novartis pursues development of Src kinase inhibitors for osteoporosis

Oct. 6, 1999

rhPM-1 inhibits synovial cell proliferation in vitro, inflammatory cell infiltration in vivo

Oct. 5, 1999

Bacterial efflux pump inhibitors developed at Microcide and presented at ICAAC meeting

Oct. 5, 1999

New class of oxazolidinones with broader spectrum presented at ICAAC by Pharmacia & Upjohn

Oct. 5, 1999

Lipopeptide synthesized at Abbott may be therapeutically useful antifungal agent

Oct. 5, 1999

Potent phenylisoxazoline antimicrobial agents designed at Pharmacia & Upjohn

Oct. 5, 1999

Lilly and Synaptic investigate potential of 5-HT1A antagonist in nicotine withdrawal

Oct. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...